Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.2T | 2.5T | 2.1T | 2.5T |
| Cost of revenue | 1.8T | 2.0T | 1.8T | 2.0T |
| Gross profit | 421.3B | 562.4B | 322.3B | 539.0B |
| Operating expense | ||||
| Research & development | 6.5B | 5.7B | 4.2B | 4.6B |
| Selling general and admin | 314.7B | 334.9B | 272.5B | 293.9B |
| Other operating expenses | 3.8B | -43M | 80M | 3.1B |
| Operating income | 21.8B | 141.6B | -27.9B | 163.3B |
| Non operating interest income | ||||
| Income | 10.4B | 11.2B | 10.7B | 11.6B |
| Expense | 3.8B | 3.9B | 4.3B | 4.7B |
| Other income expense | — | — | — | — |
| Pretax income | 27.0B | 152.4B | -24.9B | 157.8B |
| Tax provision | 5.4B | 35.7B | -3.4B | 31.2B |
| Net income | 21.7B | 116.7B | -21.4B | 126.6B |
| Basic EPS | 5 | — | — | — |
| Diluted EPS | 5 | — | — | — |
| Basic average shares | 4.2B | — | — | — |
| Diluted average shares | 4.2B | — | — | — |
| EBITDA | 51.1B | 179.9B | -1.2B | 199.3B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -31M | -48M | -2M | 23M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |